{"nct_id":"NCT05630755","title":"A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2023-02-17","start_date_type":"ACTUAL","primary_completion_date":"2024-10-25","primary_completion_date_type":"ACTUAL","completion_date":"2028-08-04","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}